Osaic Holdings
VRCA icon

Osaic Holdings’s Verrica Pharmaceuticals VRCA Stock Holding History

Osaic Holdings’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-568
Closed -$301 – 8205
2025
Q3 		$301 Buy
568
+511
+896% +$3.08K ﹤0.01% 7638
2025
Q2 		$301 Hold
57
– – ﹤0.01% 7449
2025
Q1 		$249 Sell
57
-20
-26% -$129 ﹤0.01% 7134
2024
Q4 		$537 Hold
77
– – ﹤0.01% 7005
2024
Q3 		$1.11K Buy
77
+57
+285% +$2.57K ﹤0.01% 6811
2024
Q2 		$1.46K Buy
20
+10
+100% +$768 ﹤0.01% 6710
2024
Q1 		$592 Hold
10
– – ﹤0.01% 6788
2023
Q4 		$732 Hold
10
– – ﹤0.01% 6836
2023
Q3 		$389 Buy
+10
New +$508 ﹤0.01% 7036
2021
Q4 		– Sell
-120
Closed -$15K – 7590
2021
Q3 		$15K Buy
120
+50
+71% +$5.61K ﹤0.01% 5967
2021
Q2 		$8K Buy
+70
New +$8.48K ﹤0.01% 6216
2020
Q4 		– Sell
-12
Closed -$1K – 6583
2020
Q3 		$1K Hold
12
– – ﹤0.01% 6090
2020
Q2 		$1K Hold
12
– – ﹤0.01% 6004
2020
Q1 		$1K Buy
+12
New +$1.58K ﹤0.01% 5938

Other funds holding VRCA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Osaic Holdings's VRCA Position: Q4 2025 in Review

Osaic Holdings sold out of Verrica Pharmaceuticals (VRCA) in Q4 2025, closing a stake of 568 shares — an estimated $301 sold.

Osaic Holdings first reported a position in VRCA in Q1 2020 and held it in 14 quarters. The position peaked at $15K in Q3 2021. 50 funds tracked by Wall St. Rank hold VRCA as of Q4 2025.

  • Osaic Holdings reported no remaining Verrica Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 568 Verrica Pharmaceuticals shares in Q4 2025, an estimated $301.
  • Osaic Holdings first reported a position in Verrica Pharmaceuticals in Q1 2020 and held it in 14 quarters.
  • Osaic Holdings's Verrica Pharmaceuticals position peaked at $15K in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.